Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

62.17
Delayed Data
As of May 01
 +1.75 / +2.90%
Today’s Change
47.36
Today|||52-Week Range
68.75
+8.10%
Year-to-Date
What's It Worth? Merger Mania Means Generic-Drug Makers Disagree
8:05am / MotleyFool.com
Benzinga's M&A Chatter for Monday April 27, 2015
Apr 28 / Benzinga
Teva Pharmaceuticals (TEVA) Earnings Report: Q1 2015 Conference Call Transcript
May 01 / TheStreet.com
Mylan Rejects Teva's Unsolicited Bid, While Teva Reiterates Its Original Offer
Apr 27 / TheStreet.com
Teva Pharmaceutical Industries Ltd Posts Solid Quarter, Stays Mum on Mylan
Apr 30 / MotleyFool.com
Will Teva (TEVA) Stock be Helped Today by Its Intent to Pursue Mylan Merger?
Apr 27 / TheStreet.com
Teva Pharmaceutical Industries Ltd. Posts Strong First-Quarter Earnings: Is the Stock...
Apr 30 / MotleyFool.com
Perrigo Rejects Mylan's Offer Again, Cites Undervaluation - Analyst Blog
Apr 27 / Zacks.com
Teva (TEVA) Beats on 1Q Earnings & Revenues, Raises Outlook - Tale of the Tape
Apr 30 / Zacks.com
Big Pharma Comes Under Attack From a New Hedge Fund Strategy
Apr 26 / MotleyFool.com
Teva Beats on Q1 Earnings by Wide Margin, Ups View - Analyst Blog
Apr 30 / Zacks.com
Are Biosimilars the Next Big Thing in Biotech?
Apr 25 / MotleyFool.com
Teva Beats Q1 Estimates, Raises Full-Year Forecast
Apr 30 / Benzinga
Teva-Active Biotech Start Phase II on MS Drug - Analyst Blog
Apr 24 / Zacks.com
Earnings Scheduled For April 30, 2015
Apr 30 / Benzinga
Will Biogen's (BIIB) Earnings Streak Continue in 1Q? - Analyst Blog
Apr 23 / Zacks.com
Is Exelixis (EXEL) Likely to Report Narrower Loss in Q1? - Analyst Blog
Apr 29 / Zacks.com
Teva Proposes to Buy Mylan, Sends Shares Up - Analyst Blog
Apr 22 / Zacks.com
Mylan Raises Its Offer for Generics Counterpart Perrigo
Apr 29 / TheStreet.com
Surprising stocks push Nasdaq closer to record
Apr 22 / CNNMoney.com
3 Drugs Stocks Driving The Industry Higher
Apr 29 / TheStreet.com
Stock Market News for April 22, 2015 - Market News
Apr 22 / Zacks.com
Will Teva's (TEVA) Earnings Streak Continue in Q1? - Analyst Blog
Apr 28 / Zacks.com
Perrigo Beats on Q3 Earnings, Gives View, Rejects Mylan Bid - Analyst Blog
Apr 22 / Zacks.com
Will Vertex (VRTX) Surprise with a Lower Loss in Q1? - Analyst Blog
Apr 28 / Zacks.com
Why Mylan NV Is Suddenly in the Driver's Seat
Apr 21 / MotleyFool.com
Stock Market News for April 28, 2015 - Market News
Apr 28 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account